Appeal No. 2001-2413
Application No. 09/167,894
1. A perfusion apparatus for the prolonged delivery of gene
therapy pharmaceuticals in a perfusate to target tissues
comprising a means for allowing the conduction of perfusate, a
reservoir for the perfusate, a means for propelling the
perfusate, a means for oxygenating the perfusate, and suitable
means for connecting the apparatus to the target wherein the
reservoir, means for propelling the perfusate, means for
oxygenating the perfusate and target organ are serially connected
by a means to allow the conduction of perfusate.
7. A perfusion system for the delivery of pharmaceuticals
in a perfusate to target tissues, said system comprising a
perfusate solution containing gene therapy pharmaceuticals
wherein said perfusate solution is maintained at a temperature of
about 37°C, a means for allowing the conduction of perfusate, a
reservoir for the perfusate, a means for propelling the
perfusate, a means for oxygenating the perfusate, and suitable
means for connecting the apparatus to a target tissue wherein the
reservoir, means for propelling the perfusate, means for
oxygenating the perfusate and target tissue are serially
connected by a means to allow the conduction of perfusate.
THE PRIOR ART
The reference relied on by the examiner to support the final
rejection is:
Sadri 5,338,662 August 16, 1994
THE REJECTIONS
Claim 1 stands rejected under 35 U.S.C. § 102(e) as being
anticipated by Sadri.
limitations refer to the same structure.
2
Page: Previous 1 2 3 4 5 6 7 8 9 Next
Last modified: November 3, 2007